Navigation Links
Patients With Asthma and Seasonal Allergies Respond Better to Advair(R) for Their Asthma Than Singulair(TM)
Date:5/18/2008

Study Suggests that Adding Singulair to Advair Offers no Additional

Improvement in Overall Asthma Control

RESEARCH TRIANGLE PARK, N.C. and TORONTO, May 18 /PRNewswire-FirstCall/ -- Patients with both asthma and allergic rhinitis, or seasonal allergies, experience significantly better lung function when treated with Advair Diskus(R) (fluticasone propionate and salmeterol inhalation powder) as compared with Singulair (montelukast sodium). The results of the 660-subject study were presented today at the International Conference of the American Thoracic Society meeting in Toronto.

The study also showed patients treated with Advair plus Singulair saw no measurable improvement compared to patients treated with Advair alone in their asthma symptoms or albuterol use. In another comparison patients using Advair plus the intranasal corticosteroid, fluticasone propionate nasal spray, saw significant improvement in daytime nasal symptoms compared to patients treated with Advair plus Singulair (p<0.001).

"These findings give us a greater understanding of how to treat patients with asthma and seasonal allergies, two diseases that often are seen in tandem," said Rohit Katial, MD, National Jewish Medical Research Center. "By using the right combination of treatments, physicians can help patients gain relief from the symptoms of both diseases."

The study included people age 15 and up who had both persistent asthma and seasonal allergies. Patients received one of four different treatments: Advair Diskus 100/50 twice daily, Singulair 10 mg once daily, Advair 100/50 twice daily with Singulair 10 mg once daily or Advair 100/50 twice daily with fluticasone propionate nasal spray 200 mcg once daily. Those who received Advair alone had significant improvements in their morning peak expiratory flow, a measure of asthma control, as compared with Singulair alone (p<0.001). Secondary endpoints, including symptom-free days and rescue-treat
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma
2. Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings
3. Pharmacopeias First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients
4. New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients
5. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
6. Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer
7. Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
8. New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R)
9. AviaraDx Confirms That Combination of Two Molecular Biomarkers Improves Prediction of Disease Recurrence in Early Stage Breast Cancer Patients
10. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
11. Prism Glasses Expand the View for Patients with Hemianopia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...wswire-FirstCall/--TransceptPharmaceuticals,Inc.(N...withtheU.S.FoodandDrugAdministration(FDA)onJanuary...theNewDrugApplication(NDA)for Intermezzo ® (...unced,theCompleteResponseLetter,receivedbyTranscep...vetheNDAinitspresentform.TheNDAseeksapprovaltomark...
(Date:11/23/2009)...swire-FirstCall/--Amgen(Nasdaq: AMGN )washonoredwi...andforBestNewDrugforNplate®(romiplostim),ataN...eawardwaspresentedtoAmgenbyScripinrecognitionofthe...,spipeline,aswellasitsmixofcandidatesacrossdevelop...otableforitsfocusonunmetclinicalneed. ,, "Weare...
(Date:11/23/2009)...rtlinker.comannouncesthatanewmarketresearchreporti...sInvestmentOpportunities,AnalysisandForecaststo201...dia-Dental-Devices-Investment-Opportunities-Analys...e&utm_medium=pr&utm_campaign=prnewswire ...stmentOpportunities,AnalysisandForecaststo2015 ,...
Breaking Medicine Technology:Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo(R) Complete Response Letter 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 3Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 4Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 5Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 6Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 2Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 3Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 4Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 5Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 6Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 7Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 8Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 9Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 10Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 11Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 12Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 13Common chemotherapy drug triggers fatal allergic reactions 8748 1Common chemotherapy drug triggers fatal allergic reactions 8748 2Common chemotherapy drug triggers fatal allergic reactions 8748 3Nonin Medical Introduces Next Generation Regional Oximeter at Euroanaesthesia 2009 48203 1Nonin Medical Introduces Next Generation Regional Oximeter at Euroanaesthesia 2009 48203 2Sleeplessness a Weighty Matter 48202 1Sleeplessness a Weighty Matter 48202 2
...ermillion, Inc.,(OTC Bulletin Board: VRML) announc... to extend the Strategic Alliance Agreement betwee...n will enable the companies to continue,work on th...OVA1(TM) and,VASCLIR(TM)., The OVA1 test is inten... at high risk of being malignant. Data from a 27-s...
...DHD stimulant medication with published data,demon...a pediatric clinical,study, CHICAGO, Oct. 29 Shi...alty biopharmaceutical company, today announced,re...ool-aged children aged,6 to 12 years with Attentio...tudy, researchers found that VYVANSE controlled AD...
Other Medicine Technology:Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc. 2Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc. 3Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc. 4Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD 2Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD 3Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD 4Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD 5Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD 6Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD 7
(Date:11/24/2009)... This November, Home Care Delivered joins...ovement to raise awareness for a disease that affe... Richmond, VA (Vocus) November 24, 2009 -- In co...ADA), Home Care Delivered recognizes National Di...he month of November. Nearly 24 million Americans ...
(Date:11/24/2009)...,Nov.24/PRNewswire-FirstCall/--USFarms,Inc.,(PinkS...dWellnessproductsispleasedtoannounceithasreceivedf...ssociation(AVA)foritsAloe365(TM)Juiceproduct. ,...sedtoannouncethatwehavecompletedthecertificationpr...oz.Aloe365(TM)Juice.TheprimarygoaloftheAVAistoprov...
(Date:11/24/2009)...LLE,N.C.,Nov.24/PRNewswire/--TheAmericanSocietyofE...asurveyabouttheimpactofthe2010CMSPhysicianFeeSched...istsandcardiovascularultrasoundtechnicianssurveyed...pacceptingMedicarepatients,reducestafforshutdownth...cesstoechocardiography(heartultrasound)andothervit...
(Date:11/24/2009)...ed with online predators, but few fear cyberbullyi...ealthDay News) -- More than four in five parents s...upervision, but at the same time almost two-thirds...has found. , The findings, released online Nov....Poll on Children,s Health, show that parents have ...
(Date:11/24/2009)...,Israel,November24/PRNewswire-FirstCall/--ICL(TASE...lscompany,todayreported,resultsforthethirdquartera...lResultsfortheThirdQuarter , Revenues:Revenue...scomparedsequentiallywith$1,083millionforthesecond...e$2,178million,reflecting,theexceptionaldemandandp...
Breaking Medicine News(10 mins):Health News:Home Care Delivered, Inc. Recognizes November as National Diabetes Awareness Month 2Health News:Home Care Delivered, Inc. Recognizes November as National Diabetes Awareness Month 3Health News:US Farms, Inc. Receives American Vegetarian Association Certification Approval for Aloe365(TM) Juice Product 2Health News:Lives Compromised and Patient Access Limited with New Cuts to Medicare 2Health News:Parents Worry About Their Kids' Safety on the Internet 2Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 2Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 3Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 4Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 5Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 6Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 7
...of the most prestigious awards in nursing, The Mag...al (AMH) for its Daily CARE Plan at the National M...This was the sixth year the award was presented. ...bington Memorial Hospital (AMH) for its Daily CAR...
... a commitment to helping seniors and their familie...HealthCare Partners Medical Group and Affiliated P...care Benefits for 2009" comparison presentati...t to helping seniors and their families understand...
...thCare Partners is being recognized as one of the ...Integrated Healthcare Association for the fifth st...ur California Physicians groups in the greater Los...tners was named by the Integrated Healthcare Assoc...
...er in mobile computing and medication carts unveil...odate most laptop models. , ...olumbus, OH based medical product developer, Artro...uter carts allow hospitals to fully mobilize their...
...er 11 , - Guests Will Bounce Back to Health Using...ing healthy in these stressful times is a challeng...h Retreats early in 2009 may provide,participants ... bouncing gently on a mini-trampoline several time...
... The 2008 Frost &,Sullivan European Health Ingredi... recognition of its pioneering efforts in developi... health problems., "Rather than cure, current med...ORTIGEL(R) represents the first,ingredient in both...
Other Medicine News:Health News:Abington Memorial One of Just Six Hospitals in the U.S. to Win Magnet Prize 2Health News:Abington Memorial One of Just Six Hospitals in the U.S. to Win Magnet Prize 3Health News:Healthcare Partners Medical Group to Host Free Medicare Benefits Presentations 2Health News:Healthcare Partners Medical Group to Host Free Medicare Benefits Presentations 3Health News:Healthcare Partners Medical Group to Host Free Medicare Benefits Presentations 4Health News:HealthCare Partners Rated A 'Top Performing California Physician Group' By IHA For the Fifth Straight Year 2Health News:HealthCare Partners Rated A 'Top Performing California Physician Group' By IHA For the Fifth Straight Year 3Health News:Mobile Computing Carts Leader to Release New Clinical Computer Cart 2Health News:New Health Retreat Gives a Fresh Attitude Towards Disease Prevention 2Health News:Frost & Sullivan Honours GELITA for Developing European Health Ingredient of the Year 2Health News:Frost & Sullivan Honours GELITA for Developing European Health Ingredient of the Year 3
Pocket Sports Medicine
...s enable all those involved with healthcare decisi...ce in their field of interest - a challenge which ... increases. Cochrane Reviews solve this problem by...ontinually updated evidence-based medical informat...
PocketMedicine/IM-Neurology
...s enable all those involved with healthcare decisi...ce in their field of interest - a challenge which ... increases. Cochrane Reviews solve this problem by...ontinually updated evidence-based medical informat...
Medicine Products: